ArticleImmunoTargets and therapy2025

Comparative Effectiveness and Safety of Molecular Targeted Therapy Plus PD-(L)1 with or without TACE in Unresectable Hepatocellular Carcinoma: A Retrospective Study.

Jiangtao Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.